Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of ursodeoxycholic acid for Parkinson's disease
ISRCTN73371260Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Ursodeoxycholic acid with Placebo (2 arms). Primary endpoints: Number of serious adverse events, Number of adverse treatment reactions and 1 more. Started Dec 2018; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ISRCTN73371260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73371260.